Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001215181 | SCV001386911 | pathogenic | Deficiency of galactokinase | 2023-08-18 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Experimental studies have shown that disruption of this splice site affects GALK1 function (PMID: 10790206). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 944717). Disruption of this splice site has been observed in individual(s) with galactokinase deficiency (PMID: 10790206). This variant is present in population databases (no rsID available, gnomAD 0.009%). This sequence change affects a donor splice site in intron 4 of the GALK1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in GALK1 are known to be pathogenic (PMID: 7670469, 10790206). |
Baylor Genetics | RCV001215181 | SCV005058779 | likely pathogenic | Deficiency of galactokinase | 2023-12-28 | criteria provided, single submitter | clinical testing |